Frequently Asked Questions

As ECEGEN, we are pleased to serve you between 08.00-18.00 on weekdays and Saturdays.

No, it can be done at any hour of the day that is convenient for you.

If a mother or father has a disease that can be inherited, or if the mother or father is a carrier for any disease, those individuals can acquire this disease. For example, an individual whose mother and father are both carriers for Mediterranean anemia (thalassemia) has a 25% risk of being born with thalassemia.

Technically, it is a test that can be performed on anyone who requests it. It is especially important for couples who have had a pregnancy with a genetic disease before, individuals with a family history of genetic disease carrier status, couples with consanguineous marriages, and individuals in high-risk ethnic groups.

Although NIPT is recommended for all pregnant women, it is especially recommended for mothers aged 35 and over, those with a history of chromosomal abnormalities in previous pregnancies, ultrasonographic findings showing increased risk of aneuploidy, or a history of recurrent miscarriage.

According to ACMG guidelines; it can be performed in patients whose family history shows genetic etiology but is not compatible with a specific disorder, in cases where it is practical to study multiple genes simultaneously due to high genetic heterogeneity, and in cases that cannot be diagnosed with previous analyses.

Individuals with hereditary cancer in their family, those diagnosed with breast cancer before age 50, those with ovarian cancer at any age, patients who develop multiple breast/ovarian cancers, and cases of breast cancer in men should be evaluated as a priority.

Pharmacogenetic testing can be performed on anyone who wants to take the right drug in the right dose according to the genotype analysis performed before using drugs. Thanks to this test, effective treatment is provided and unnecessary drug use is prevented.